1. `Permax' safety information issued in Canada

   News item 08 February 2013 Pages: 2 - 2

2. `Risperdal' prescribing information updated

   News item 08 February 2013 Pages: 2 - 2

3. Australian TGA suspends Pan Pharmaceutical's manufacturing licence

   Media release 08 February 2013 Pages: 2 - 2

4. EMEA highlights important `Ketek' safety information

   News item 08 February 2013 Pages: 2 - 2

5. UK introduces patient reporting of ADRs

   Media release 08 February 2013 Pages: 2 - 2

6. Elevated lactate levels common with HAART

   Clinical study 08 February 2013 Pages: 3 - 3

7. No increase in ADR incidence in patients with SLE

   Incidence study 08 February 2013 Pages: 3 - 3

8. Nurses make valuable contribution to ADR reporting

   Clinical study 08 February 2013 Pages: 3 - 3

9. Postnatal macrolides increase risk of infantile pyloric stenosis

   Clinical study 08 February 2013 Pages: 3 - 3

10. Thyroid hormone replacement: no increase in hip fracture risk

    Incidence study 08 February 2013 Pages: 3 - 3

11. Adverse drug events in outpatients

    News item 08 February 2013 Pages: 4 - 4

12. Tocopherol reduces cisplatin-induced neuropathy

    Clinical study 08 February 2013 Pages: 4 - 4

13. Aspirin resistance predictive of vascular events

    Clinical study 08 February 2013 Pages: 5 - 5

14. HRT + high caffeine intake increases risk of Parkinson's disease

    Clinical study 08 February 2013 Pages: 5 - 5

15. Mercaptopurine increases risk of fetal loss in IBD

    Clinical study 08 February 2013 Pages: 5 - 5

16. Prenatal exposure to diuretics and hypertension linked to schizophrenia

    Clinical study 08 February 2013 Pages: 5 - 5

17. Rosiglitazone increases pulmonary endothelial permeability

    In vitro 08 February 2013 Pages: 5 - 5

18. Aminophylline

    Case report 08 February 2013 Pages: 6 - 6

19. Antineoplastics

    Case report 08 February 2013 Pages: 6 - 6

20. Azathioprine/cyclosporin/prednisolone

    Case report 08 February 2013 Pages: 6 - 6

21. BCG

    Case report 08 February 2013 Pages: 6 - 7

22. Benserazide

    Case report 08 February 2013 Pages: 7 - 7

23. Benzylthiouracil

    Case report 08 February 2013 Pages: 7 - 7

24. Benzylthiouracil:

    Case report 08 February 2013 Pages: 7 - 7

25. Bupropion

    Case report 08 February 2013 Pages: 7 - 8

26. Carbamazepine

    Case report 08 February 2013 Pages: 8 - 8

27. Celecoxib

    Case report 08 February 2013 Pages: 8 - 8

28. Celecoxib

    Case report 08 February 2013 Pages: 8 - 8

29. Cerivastatin interaction

    Case report 08 February 2013 Pages: 8 - 8

30. Ciprofloxacin

    Case report 08 February 2013 Pages: 9 - 9

31. Cisplatin

    Case report 08 February 2013 Pages: 9 - 9

32. Colchicine

    Case report 08 February 2013 Pages: 9 - 9

33. Cyclosporin

    Case report 08 February 2013 Pages: 9 - 9

34. Cytarabine

    Case report 08 February 2013 Pages: 9 - 10

35. Cytarabine

    Case report 08 February 2013 Pages: 10 - 10

36. Digoxin interaction

    Case report 08 February 2013 Pages: 10 - 10

37. Dimenhydrinate overdose

    Case reports 08 February 2013 Pages: 10 - 10

38. Donepezil

    Case report 08 February 2013 Pages: 10 - 10

39. Ephedrine

    Case report 08 February 2013 Pages: 11 - 11

40. Fentanyl

    Case report 08 February 2013 Pages: 11 - 11

41. Fentanyl

    Case report 08 February 2013 Pages: 11 - 11

42. Fosphenytoin

    Case report 08 February 2013 Pages: 11 - 11

43. Gabapentin

    Case report 08 February 2013 Pages: 11 - 11

44. Gemcitabine

    Case report 08 February 2013 Pages: 11 - 11

45. Ibuprofen

    Case report 08 February 2013 Pages: 12 - 12

46. Infliximab

    Case report 08 February 2013 Pages: 12 - 12

47. Infliximab

    Case report 08 February 2013 Pages: 12 - 12

48. Insulin lispro

    Case report 08 February 2013 Pages: 12 - 12

49. Isosorbide dinitrate/nitroglycerin

    Case report 08 February 2013 Pages: 13 - 13

50. Levofloxacin

    Case report 08 February 2013 Pages: 13 - 13